Hbk Investments L P Vertex Pharmaceuticals Inc Transaction History

Hbk Investments L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $4 Million - $5.37 Million	-23,967 Reduced 94.59%	1,372 $300,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $3.24 Million - $3.85 Million	-19,761 Reduced 43.82%	25,339 $4.66 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $4.67 Million - $5.9 Million	30,712 Added 213.46%	45,100 $7.47 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $13.8 Million - $15.9 Million	-82,502 Reduced 85.15%	14,388 $2.77 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $10 Million - $11.7 Million	68,690 Added 243.58%	96,890 $16.5 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $16.4 Million - $19.2 Million	-108,505 Reduced 79.37%	28,200 $4.6 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $3.28 Million - $3.72 Million	-23,895 Reduced 14.88%	136,705 $20.5 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $23.8 Million - $26.1 Million	160,600	160,600 $24.4 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.